← FDA Drug Approvals (Drugs@FDA)

NGENLA

BLA · Biologics License Application · Sponsor: PFIZER IRELAND PHARMACEUTICALS · Approved 2023-06-27

Drug application

FDA Application #

BLA761184

Application type

Biologics License Application

Brand name

NGENLA

Generic name

SOMATROGON-GHLA

Active ingredients

SOMATROGON-GHLA

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

PFIZER IRELAND PHARMACEUTICALS

Manufacturer

Pfizer Laboratories Div Pfizer Inc

First approval

2023-06-27

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown